Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Feliciano Barron, Martha de la Torre-Vallejo, Rosa Luz Luna-Palencia, Andres F Cardona & Oscar Arrieta. (2016) The safety of afatinib for the treatment of non-small cell lung cancer. Expert Opinion on Drug Safety 15:11, pages 1563-1572.
Read now
Read now
Articles from other publishers (12)
Yuko Kanbayashi, Momoko Kobayashi, Miku Anzai, Tadashi Shimizu & Mayako Uchida. (2023) Evaluation of Time to Onset and Outcome of Lung Adverse Events Related to Pembrolizumab Using Marketing Surveillance. Oncology, pages 817-821.
Crossref
Crossref
Vickie R. Shannon, George A. Eapen, Carlos A. Jimenez, Horiana B. Grosu, Rodolfo C. Morice, Lara Bashoura, Ajay Sheshadre, Scott E. Evans, Roberto Adachi, Michael Kroll, Saadia A. Faiz, Diwakar D. Balachandran, Selvaraj E. Pravinkumar & Burton F. Dickey. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
37
.
Yuko Kanbayashi, Mayako Uchida, Misui Kashiwagi, Hitomi Akiba & Tadashi Shimizu. (2022) Evaluation of lung adverse events with trastuzumab using the Japanese pharmacovigilance database. Medical Oncology 39:12.
Crossref
Crossref
Manuel Ramos-Casals, Alejandra Flores-Chávez, Pilar Brito-Zerón, Olivier Lambotte & Xavier Mariette. (2022) Immune-related adverse events of cancer immunotherapies targeting kinases. Pharmacology & Therapeutics 237, pages 108250.
Crossref
Crossref
Faridah Ismail, Yusmazura Zakaria, Nik Fakhuruddin Nik Hassan & Muhammad Lokman Md Isa. (2022) Malaysian herbs as potential natural resources of anticancer drugs: From folklore to discovery. Asia Pacific Journal of Molecular Biology and Biotechnology, pages 62-89.
Crossref
Crossref
Ricardo J. José, Saadia A. Faiz & Vickie R. Shannon. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
931
949
.
Lu Xie, Jie Xu, Wei Guo, Zhen Wang, Yang Yao, Jianmin Li, Jianhua Lin, Jianru Xiao, Xiuchun Yu, Weibin Zhang, Zhendong Cai, Yingqi Hua, Jing Chen, Zengwu Shao, Di Wu, Sujia Wu, Zhongqi Tu & Xiaojing Zhang. (2021) Management of Apatinib-Related Adverse Events in Patients With Advanced Osteosarcoma From Four Prospective Trials: Chinese Sarcoma Study Group Experience. Frontiers in Oncology 11.
Crossref
Crossref
Anqi Wang, Yan Xu, Yunyun Fei & Mengzhao Wang. (2020) The role of immunosuppressive agents in the management of severe and refractory immune‐related adverse events. Asia-Pacific Journal of Clinical Oncology 16:4, pages 201-210.
Crossref
Crossref
Annelieke E. C. A. B. Willemsen, Jolien Tol, Nielka P. van Erp, Marianne A. Jonker, Maaike de Boer, Bob Meek, Paul C. de Jong, Coline van Moorsel, Winald R. Gerritsen, Jan C. Grutters & Carla M. L. van Herpen. (2019) Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane. Targeted Oncology 14:4, pages 441-451.
Crossref
Crossref
P.-G. Forkert. 2019. Encyclopedia of Environmental Health. Encyclopedia of Environmental Health
577
588
.
A. Parrot, A. Gibelin, T. Issoufaly, G. Voiriot, M. Djibré, J.M. Naccache, J. Cadranel & M. Fartoukh. (2018) Toxicité pulmonaire des médicaments : ce que le réanimateur doit connaître ?. Médecine Intensive Réanimation 27:1, pages 45-56.
Crossref
Crossref
Elie Azoulay, Peter Schellongowski, Michael Darmon, Philippe R. Bauer, Dominique Benoit, Pieter Depuydt, Jigeeshu V. Divatia, Virginie Lemiale, Maarten van Vliet, Anne-Pascale Meert, Djamel Mokart, Stephen M. Pastores, Anders Perner, Frédéric Pène, Peter Pickkers, Kathryn A. Puxty, Francois Vincent, Jorge Salluh, Ayman O. Soubani, Massimo Antonelli, Thomas Staudinger, Michael von Bergwelt-Baildon & Marcio Soares. (2017) The Intensive Care Medicine research agenda on critically ill oncology and hematology patients. Intensive Care Medicine 43:9, pages 1366-1382.
Crossref
Crossref